Abiopharma

New Form 8-K - BioXcel Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0001104659-25-076214 Size: 214 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits